Facing significant recruitment and operational challenges with their osteoarthritic knee pain study, a biotech company turned to Worldwide Clinical Trials to transition and deliver the study successfully. Discover how our expert team at Worldwide Clinical Trials turned around a failing study, ensuring successful outcomes in record time, and learn more about our strategic approaches and personalized solutions that make us a trusted partner in clinical research.
Our strategic transition addressed several critical challenges:
- Slow site activation due to staffing issues and delays in site identification
- Unmet recruitment projections and high screen failure rates impacting participant eligibility
- Lack of dedicated and agile support from the previous CRO, leading to ongoing trial delays and additional costs
